Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer

Firmagon (degarelix) - Astellas, Ferring

Orgovyx (relugolix) - Takeda, Sumitomo Pharma, Pfizer

leuprolide acetate for depot suspension - Generic mfg.

Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer (clinicaltrials.gov) - Sep 4, 2026 - P2 | N=90 | Recruiting | Sponsor: NYU Langone Health
New P2 trial • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor

http://clinicaltrials.gov/ct2/show/NCT07801664

Sep 4, 2026